Pharmaceutical Business Intelligence

  • Predict branded drug patent expiration
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

KLOR-CON Drug Profile

« Back to Dashboard

Which patents cover Klor-con, and what substitute generic drugs are available?

Klor-con is a drug marketed by Upsher-smith Labs and Upsher Smith Labs and is included in three NDAs.

The generic ingredient in KLOR-CON is potassium chloride. There are two hundred and twenty-six drug master file entries for this compound. Seventy-three suppliers are listed for this compound. There are two tentative approvals for this compound. Additional details are available on the potassium chloride profile page.

Summary for Tradename: KLOR-CON

Suppliers / Packagers: see list20
Bulk Api Vendors: see list127
Clinical Trials: see list16
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:KLOR-CON at DailyMed

Pharmacology for Tradename: KLOR-CON

Ingredient-typePotassium Compounds
Drug ClassPotassium Salt
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher-smith Labs
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL203106-001Jul 10, 2015RXNoNo► Subscribe► Subscribe
Upsher Smith Labs
potassium chloride
TABLET, EXTENDED RELEASE;ORAL074726-001Nov 20, 1998RXNoYes► Subscribe► Subscribe
Upsher-smith Labs
potassium chloride
TABLET, EXTENDED RELEASE;ORAL019123-002Apr 17, 1986RXYesYes► Subscribe► Subscribe
Upsher-smith Labs
potassium chloride
CAPSULE, EXTENDED RELEASE;ORAL203106-002Jul 10, 2015RXNoNo► Subscribe► Subscribe
Upsher-smith Labs
potassium chloride
TABLET, EXTENDED RELEASE;ORAL019123-001Apr 17, 1986RXYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.